Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
ORGO Organogenesis
- 4.530
- +0.080+1.80%
Close Apr 24 16:00 ET
- 4.530
- 0.0000.00%
Post 16:05 ET
574.53MMarket Cap-453.00P/E (TTM)
4.605High4.410Low3.87MVolume4.460Open4.450Pre Close17.53MTurnover6.96%Turnover RatioLossP/E (Static)126.83MShares6.71052wk High2.19P/B251.65MFloat Cap2.21052wk Low--Dividend TTM55.55MShs Float310.900Historical High--Div YieldTTM4.38%Amplitude1.795Historical Low4.532Avg Price1Lot Size
Organogenesis News
Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access With High Quality Evidence of Effectiveness
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Further Weakness as Organogenesis Holdings (NASDAQ:ORGO) Drops 10% This Week, Taking Three-year Losses to 50%
Insider-Favored Growth Companies Including Organogenesis Holdings And Two More
Organogenesis Highlights Strategic Focus in Investor Presentation
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Cantor Fitzgerald Maintains Organogenesis(ORGO.US) With Buy Rating, Maintains Target Price $6
Insider Sale: Director at $ORGO Sells 25,000 Shares
Express News | Organogenesis Shares Are Trading Higher After Morgan Stanley Raised Its Price on the Stock From $4 to $6
Organogenesis Holdings Is Maintained at Equal-Weight by Morgan Stanley
Organogenesis Holdings Analyst Ratings
Morgan Stanley Maintains Organogenesis(ORGO.US) With Hold Rating, Raises Target Price to $6
BTIG Maintains Organogenesis(ORGO.US) With Buy Rating, Maintains Target Price $7
Stocks That Could Be Safe From Tariffs Risk Compared to Their Industry Peers
Organogenesis Holdings Inc. (NASDAQ:ORGO) Held Back By Insufficient Growth Even After Shares Climb 69%
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges
Trending Stocks Today | Longeveron Surges 25% Post-Market
Trending Stocks Today | Aclarion Shoots up 56.72%
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
